Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS)
TARS Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
25.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
62.40%
TARS Stock Analysis
TARS
PE Ratio:
TARS
PEG Ratio:
Not Available
TARS
Forward EPS Growth (12 month):
0.00%
TARS
PS Ratio:
4.7
TARS
PSG Ratio:
0.2
TARS
Forward Revenue Growth (12 month):
30.20%
TARS Articles
No data was found